Ito Hospital Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2010
NCT01805856
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Ito ENT Clinic

Active Ingredients

Drugs in Phase 3 Trials (1)

live attenuated influenza virus vaccine (Flumist) (1 trial)

Drugs in Other Trials (2)

cefazolin (ancef) (1 trial)

piperacillin (pipracil) (1 trial)

Indications

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3